Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

A pancreatic mucinous cystic neoplasm undergoing intriguing morphological changes over time and associated with recurrent pancreatitis: A case report.

Shioyama E, Mitoro A, Ogawa H, Kubo T, Ozutsumi T, Kitagawa K, Yoshikawa M, Ueda S, Akahori T, Marugami NA, Hatakeyama K, Yamao J, Sho M, Ohbayashi C, Yoshiji H.

Medicine (Baltimore). 2019 Jul;98(28):e16435. doi: 10.1097/MD.0000000000016435.

2.

Female Fertility Preservation through Stem Cell-based Ovarian Tissue Reconstitution In Vitro and Ovarian Regeneration In Vivo.

Akahori T, Woods DC, Tilly JL.

Clin Med Insights Reprod Health. 2019 May 23;13:1179558119848007. doi: 10.1177/1179558119848007. eCollection 2019. Review.

3.

Significance of the inflammation-based prognostic score in recurrent pancreatic cancer.

Nakagawa K, Sho M, Akahori T, Nagai M, Nakamura K, Takagi T, Tanaka T, Nishiofuku H, Ohbayashi C, Kichikawa K, Ikeda N.

Pancreatology. 2019 Jul;19(5):722-728. doi: 10.1016/j.pan.2019.05.461. Epub 2019 May 23.

PMID:
31153778
4.

A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy.

Katsuda M, Miyazawa M, Ojima T, Katanuma A, Hakamada K, Sudo K, Asahara S, Endo I, Ueno M, Hara K, Yamada S, Fujii T, Satoi S, Ioka T, Ohira M, Akahori T, Kitano M, Nagano H, Furukawa M, Adachi T, Yamaue H.

Trials. 2019 Apr 27;20(1):242. doi: 10.1186/s13063-019-3332-5.

5.

Phase II Study of the Triple Combination Chemotherapy of SOXIRI (S-1/Oxaliplatin/Irinotecan) in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.

Akahori T, Sho M, Yanagimoto H, Satoi S, Nagai M, Nishiwada S, Nakagawa K, Nakamura K, Yamamoto T, Hirooka S, Yamaki S, Ikeda N.

Oncologist. 2019 Jun;24(6):749-e224. doi: 10.1634/theoncologist.2018-0900. Epub 2019 Jan 24.

6.

Evaluation of optic nerve head blood flow in response to increase of intraocular pressure.

Iwase T, Akahori T, Yamamoto K, Ra E, Terasaki H.

Sci Rep. 2018 Nov 22;8(1):17235. doi: 10.1038/s41598-018-35683-y.

7.

Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PD.

Maeda H, Okada KI, Fujii T, Oba MS, Kawai M, Hirono S, Kodera Y, Sho M, Akahori T, Shimizu Y, Ambo Y, Kondo N, Murakami Y, Ohuchida J, Eguchi H, Nagano H, Sakamoto J, Yamaue H.

Oncol Lett. 2018 Nov;16(5):6847-6853. doi: 10.3892/ol.2018.9422. Epub 2018 Sep 7.

8.

Novel Classification of Early-stage Systemic Hypertensive Changes in Human Retina Based on OCTA Measurement of Choriocapillaris.

Takayama K, Kaneko H, Ito Y, Kataoka K, Iwase T, Yasuma T, Matsuura T, Tsunekawa T, Shimizu H, Suzumura A, Ra E, Akahori T, Terasaki H.

Sci Rep. 2018 Oct 11;8(1):15163. doi: 10.1038/s41598-018-33580-y.

9.

A Comparison Between Plastic and Metallic Biliary Stent Placement in Patients Receiving Preoperative Neoadjuvant Chemoradiotherapy for Resectable Pancreatic Cancer.

Nakamura K, Sho M, Akahori T, Nagai M, Nishiwada S, Nakagawa K, Tanaka T, Kichikawa K, Tamamoto T, Hasegawa M, Mitoro A, Yoshiji H, Ikeda N.

World J Surg. 2019 Feb;43(2):642-648. doi: 10.1007/s00268-018-4820-6.

PMID:
30298284
10.

Risk Factors for Late-Onset Gastrointestinal Hemorrhage After Pancreatoduodenectomy for Pancreatic Cancer.

Nagai M, Sho M, Akahori T, Nishiwada S, Nakagawa K, Nakamura K, Tanaka T, Nishiofuku H, Kichikawa K, Ikeda N.

World J Surg. 2019 Feb;43(2):626-633. doi: 10.1007/s00268-018-4791-7.

PMID:
30225561
11.

Prognostic factors for actual long-term survival in the era of multidisciplinary treatment for pancreatic ductal adenocarcinoma.

Nakagawa K, Akahori T, Nishiwada S, Nagai M, Nakamura K, Tanaka T, Tamamoto T, Ohbayashi C, Hasegawa M, Kichikawa K, Ikeda N, Sho M.

Langenbecks Arch Surg. 2018 Sep;403(6):693-700. doi: 10.1007/s00423-018-1709-7. Epub 2018 Sep 15.

PMID:
30218193
12.

Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.

Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.

Clin Exp Nephrol. 2018 Dec;22(6):1266-1280. doi: 10.1007/s10157-018-1579-x. Epub 2018 Apr 20.

PMID:
29679356
13.

Macular Displacement After Vitrectomy in Eyes With Idiopathic Macular Hole Determined by Optical Coherence Tomography Angiography.

Akahori T, Iwase T, Yamamoto K, Ra E, Kawano K, Ito Y, Terasaki H.

Am J Ophthalmol. 2018 May;189:111-121. doi: 10.1016/j.ajo.2018.02.021. Epub 2018 Mar 2.

PMID:
29505776
14.

Significance of bacterial culturing of prophylactic drainage fluid in the early postoperative period after liver resection for predicting the development of surgical site infections.

Ishioka K, Hokuto D, Nomi T, Yasuda S, Yoshikawa T, Matsuo Y, Akahori T, Nishiwada S, Nakagawa K, Nagai M, Nakamura K, Ikeda N, Sho M.

Surg Today. 2018 Jun;48(6):625-631. doi: 10.1007/s00595-018-1629-8. Epub 2018 Jan 29.

PMID:
29380135
15.

Lambert-Eaton myasthenic syndrome with anti-acetylcholine receptor antibody and anterior mediastinal tumor.

Matsumoto H, Ohtomo G, Akahori T, Hashida H.

J Gen Fam Med. 2017 Apr 13;18(5):282-284. doi: 10.1002/jgf2.66. eCollection 2017 Oct.

16.

Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma? -Multicenter surgical group study.

Yamamoto T, Satoi S, Kawai M, Motoi F, Sho M, Uemura KI, Matsumoto I, Honda G, Okada KI, Akahori T, Toyama H, Kurata M, Yanagimoto H, Yamaue H, Unno M, Kon M, Murakami Y.

Pancreatology. 2018 Jan;18(1):106-113. doi: 10.1016/j.pan.2017.11.005. Epub 2017 Nov 14.

PMID:
29153701
17.

Reinforced staplers for distal pancreatectomy.

Kawai M, Hirono S, Okada KI, Satoi S, Yanagimoto H, Kon M, Murakami Y, Kondo N, Sho M, Akahori T, Toyama H, Fukumoto T, Fujii T, Matsumoto I, Eguchi H, Ikoma H, Takeda Y, Fujimoto J, Yamaue H.

Langenbecks Arch Surg. 2017 Dec;402(8):1197-1204. doi: 10.1007/s00423-017-1634-1. Epub 2017 Nov 4.

PMID:
29103084
18.

Changes in Choroidal Blood Flow and Morphology in Response to Increase in Intraocular Pressure.

Akahori T, Iwase T, Yamamoto K, Ra E, Terasaki H.

Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5076-5085. doi: 10.1167/iovs.17-21745.

PMID:
28980002
19.

Tissue oxygenation index reflects changes in forearm blood flow after brief ischemia.

Kinoshita H, Akahori T, Nakamura E, Okawa H, Kawahito S, Kitahata H, Fujiwara Y.

J Med Invest. 2017;64(3.4):228-232. doi: 10.2152/jmi.64.228.

20.

Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.

Hokuto D, Nomi T, Yasuda S, Yoshikawa T, Ishioka K, Yamada T, Akahori T, Nakagawa K, Nagai M, Nakamura K, Obara S, Kanehiro H, Sho M.

World J Surg. 2018 Mar;42(3):884-891. doi: 10.1007/s00268-017-4195-0.

PMID:
28879511
21.

Human serum albumin and oxidative stress in preeclamptic women and the mechanism of albumin for stress reduction.

Kinoshita H, Watanabe K, Azma T, Feng GG, Akahori T, Hayashi H, Sato M, Fujiwara Y, Wakatsuki A.

Heliyon. 2017 Aug 2;3(8):e00369. doi: 10.1016/j.heliyon.2017.e00369. eCollection 2017 Aug.

22.

Long-term observation and treatment of a widespread intraductal papillary neoplasm of the bile duct extending from the intrapancreatic bile duct to the bilateral intrahepatic bile duct: A case report.

Hokuto D, Nomi T, Yasuda S, Yoshikawa T, Ishioka K, Yamada T, Akahori T, Nakagawa K, Nagai M, Nakamura K, Obara S, Kanehiro H, Sho M.

Int J Surg Case Rep. 2017;38:166-171. doi: 10.1016/j.ijscr.2017.07.031. Epub 2017 Jul 23.

23.

[Huge Hepatocellular Carcinoma with Portal Vein and Inferior Vena Cava Thrombi Treated with Curative Liver Resection and Perioperative Hepatic Arterial Infusion Chemotherapy - A Case Report].

Obara S, Nomi T, Yamato I, Hokuto D, Yasuda S, Kawaguchi C, Yoshikawa T, Sho M, Yamada T, Akahori T, Kinoshita S, Nagai M, Kanehiro H, Nakajima Y.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1779-1781. Japanese.

PMID:
28133129
24.

[A Case of Advanced Hepatocellular Carcinoma, Its Disease Progression Could Be Controlled by Multimodal Treatment].

Yoshikawa T, Nomi T, Hokuto D, Yamato I, Yasuda S, Obara S, Kawaguchi C, Kinoshita S, Nishiwada S, Nagai M, Akahori T, Yamada T, Sho M, Kanehiro H, Nakajima Y.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1754-1756. Japanese.

PMID:
28133121
25.

Ovarian mature cystic teratoma with fistula formation into the rectum: a case report.

Kizaki Y, Nagai T, Ohara K, Gomi Y, Akahori T, Ono Y, Matsunaga S, Takai Y, Saito M, Baba K, Seki H.

Springerplus. 2016 Oct 3;5(1):1700. eCollection 2016.

26.

Factors associated with failure to complete adjuvant chemotherapy in pancreatic cancer.

Akahori T, Sho M, Tanaka T, Kinoshita S, Nagai M, Nishiwada S, Nishiofuku H, Ohbayashi C, Kichikawa K, Nakajima Y.

Am J Surg. 2016 Apr;211(4):787-92. doi: 10.1016/j.amjsurg.2015.10.034. Epub 2016 Jan 11.

PMID:
26846177
27.

Prognosis after surgical treatment for pancreatic cancer in patients aged 80 years or older: a multicenter study.

Sho M, Murakami Y, Kawai M, Motoi F, Satoi S, Matsumoto I, Honda G, Uemura K, Yanagimoto H, Kurata M, Akahori T, Kinoshita S, Nagai M, Nishiwada S, Fukumoto T, Unno M, Yamaue H, Nakajima Y.

J Hepatobiliary Pancreat Sci. 2016 Mar;23(3):188-97. doi: 10.1002/jhbp.320. Epub 2016 Feb 19.

PMID:
26763744
28.

Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial.

Satoi S, Sho M, Yanagimoto H, Yamamoto T, Akahori T, Kinoshita S, Nagai M, Hirooka S, Yamaki S, Nishiwada S, Ryota H, Ikeda N, Nakajima Y, Kon M.

J Hepatobiliary Pancreat Sci. 2016 Mar;23(3):167-73. doi: 10.1002/jhbp.318. Epub 2016 Feb 14.

PMID:
26748629
29.

Reappraisal of Total Pancreatectomy in 45 Patients With Pancreatic Ductal Adenocarcinoma in the Modern Era Using Matched-Pairs Analysis: Multicenter Study Group of Pancreatobiliary Surgery in Japan.

Satoi S, Murakami Y, Motoi F, Sho M, Matsumoto I, Uemura K, Kawai M, Kurata M, Yanagimoto H, Yamamoto T, Mizuma M, Unno M, Kinoshita S, Akahori T, Shinzeki M, Fukumoto T, Hashimoto Y, Hirono S, Yamaue H, Honda G, Kwon M.

Pancreas. 2016 Aug;45(7):1003-9. doi: 10.1097/MPA.0000000000000579.

PMID:
26692442
30.

Phase I study assessing the feasibility of the triple combination chemotherapy of SOXIRI (S-1/oxaliplatin/irinotecan) in patients with unresectable pancreatic ductal adenocarcinoma.

Yanagimoto H, Satoi S, Sho M, Akahori T, Yamamoto T, Hirooka S, Yamaki S, Kotsuka M, Ryota H, Kinoshita S, Nishiwada S, Nagai M, Ikeda N, Tsuta K, Nakajima Y, Kon M.

Cancer Chemother Pharmacol. 2016 Jan;77(1):35-41. doi: 10.1007/s00280-015-2928-z. Epub 2015 Dec 8.

PMID:
26645403
31.

Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study.

Matsumoto I, Murakami Y, Shinzeki M, Asari S, Goto T, Tani M, Motoi F, Uemura K, Sho M, Satoi S, Honda G, Yamaue H, Unno M, Akahori T, Kwon AH, Kurata M, Ajiki T, Fukumoto T, Ku Y.

Pancreatology. 2015 Nov-Dec;15(6):674-80. doi: 10.1016/j.pan.2015.09.008. Epub 2015 Oct 3.

PMID:
26467797
32.

Highly improved accuracy of the revised PREoperative sarcoma score (rPRESS) in the decision of performing surgery for patients presenting with a uterine mass.

Nagai T, Takai Y, Akahori T, Ishida H, Hanaoka T, Uotani T, Sato S, Matsunaga S, Baba K, Seki H.

Springerplus. 2015 Sep 17;4:520. doi: 10.1186/s40064-015-1318-7. eCollection 2015.

33.

Increased tumour ADC value during chemotherapy predicts improved survival in unresectable pancreatic cancer.

Nishiofuku H, Tanaka T, Marugami N, Sho M, Akahori T, Nakajima Y, Kichikawa K.

Eur Radiol. 2016 Jun;26(6):1835-42. doi: 10.1007/s00330-015-3999-2. Epub 2015 Sep 19.

34.

Impact of Smoking on Pancreatic Cancer Patients Receiving Current Chemotherapy.

Kawaguchi C, Sho M, Tanaka T, Akahori T, Kinoshita S, Nagai M, Yasuda S, Nishiwada S, Nishiofuku H, Kichikawa K, Nakajima Y.

Pancreas. 2015 Oct;44(7):1155-60. doi: 10.1097/MPA.0000000000000395.

PMID:
26355552
35.

Impact of preoperative asymptomatic renal dysfunction on clinical course after pancreatoduodenectomy.

Nagai M, Sho M, Akahori T, Tanaka T, Kinoshita S, Nishiofuku H, Nishiwada S, Ohbayashi C, Kichikawa K, Nakajima Y.

J Hepatobiliary Pancreat Sci. 2015 Nov;22(11):810-8. doi: 10.1002/jhbp.286. Epub 2015 Oct 14.

PMID:
26333519
36.

Kynurenine causes vasodilation and hypotension induced by activation of KCNQ-encoded voltage-dependent K(+) channels.

Sakakibara K, Feng GG, Li J, Akahori T, Yasuda Y, Nakamura E, Hatakeyama N, Fujiwara Y, Kinoshita H.

J Pharmacol Sci. 2015 Sep;129(1):31-7. doi: 10.1016/j.jphs.2015.07.042. Epub 2015 Aug 10.

37.

Prognostic Significance of Muscle Attenuation in Pancreatic Cancer Patients Treated with Neoadjuvant Chemoradiotherapy.

Akahori T, Sho M, Kinoshita S, Nagai M, Nishiwada S, Tanaka T, Tamamoto T, Ohbayashi C, Hasegawa M, Kichikawa K, Nakajima Y.

World J Surg. 2015 Dec;39(12):2975-82. doi: 10.1007/s00268-015-3205-3.

PMID:
26296840
38.

Cerebral oxygenation in the beach chair position before and during general anesthesia in patients with and without cardiovascular risk factors.

Mori Y, Yamada M, Akahori T, Hatakeyama N, Yamazaki M, Fujiwara Y, Kinoshita H.

J Clin Anesth. 2015 Sep;27(6):457-62. doi: 10.1016/j.jclinane.2015.06.007. Epub 2015 Aug 6.

PMID:
26256720
39.

Central Pancreatectomy with Double Pancreaticojejunostomy.

Sho M, Akahori T, Nagai M, Satoi S, Yanagimoto H, Kinoshita S, Yamamoto T, Ikeda N, Kwon AH, Nakajima Y.

J Am Coll Surg. 2015 Aug;221(2):e15-9. doi: 10.1016/j.jamcollsurg.2015.05.004. Epub 2015 May 13. No abstract available.

PMID:
26206657
40.

Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer.

Sho M, Akahori T, Tanaka T, Kinoshita S, Nagai M, Nishiwada S, Tamamoto T, Nishiofuku H, Ohbayashi C, Hasegawa M, Kichikawa K, Nakajima Y.

Langenbecks Arch Surg. 2015 May;400(4):477-85. doi: 10.1007/s00423-015-1304-0. Epub 2015 May 1.

PMID:
25929828
41.

Importance of resectability status in neoadjuvant treatment for pancreatic cancer.

Sho M, Akahori T, Tanaka T, Kinoshita S, Nagai M, Tamamoto T, Ohbayashi C, Hasegawa M, Kichikawa K, Nakajima Y.

J Hepatobiliary Pancreat Sci. 2015 Jul;22(7):563-70. doi: 10.1002/jhbp.258. Epub 2015 Apr 29.

PMID:
25921623
42.

Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer.

Nishiwada S, Sho M, Yasuda S, Shimada K, Yamato I, Akahori T, Kinoshita S, Nagai M, Konishi N, Nakajima Y.

J Exp Clin Cancer Res. 2015 Mar 28;34:30. doi: 10.1186/s13046-015-0144-7.

43.

Potential role of surgical resection for pancreatic cancer in the very elderly.

Kinoshita S, Sho M, Yanagimoto H, Satoi S, Akahori T, Nagai M, Nishiwada S, Yamamoto T, Hirooka S, Yamaki S, Ikeda N, Kwon AH, Nakajima Y.

Pancreatology. 2015 May-Jun;15(3):240-6. doi: 10.1016/j.pan.2015.03.015. Epub 2015 Apr 8.

PMID:
25888010
44.

Clinical significance of CD155 expression in human pancreatic cancer.

Nishiwada S, Sho M, Yasuda S, Shimada K, Yamato I, Akahori T, Kinoshita S, Nagai M, Konishi N, Nakajima Y.

Anticancer Res. 2015 Apr;35(4):2287-97. Erratum in: Anticancer Res. 2015 Jul;35(7):4371.

PMID:
25862891
45.

Concomitant sentinel lymph node biopsy leading to abbreviated systematic lymphadenectomy in a patient with primary malignant melanoma of the vagina.

Ishida H, Nagai T, Sato S, Honda M, Uotani T, Samejima K, Hanaoka T, Akahori T, Takai Y, Seki H.

Springerplus. 2015 Feb 28;4:102. doi: 10.1186/s40064-014-0773-x. eCollection 2015.

46.

Novel uterine sarcoma preoperative diagnosis score predicts the need for surgery in patients presenting with a uterine mass.

Nagai T, Takai Y, Akahori T, Ishida H, Hanaoka T, Uotani T, Sato S, Matsunaga S, Baba K, Seki H.

Springerplus. 2014 Nov 18;3:678. doi: 10.1186/2193-1801-3-678. eCollection 2014.

47.

SALL4 positive fetal gut-like adenocarcinoma of the duodenum.

Kinoshita S, Sho M, Enomoto Y, Koyama F, Akahori T, Nagai M, Ito M, Morita K, Ohbayashi C, Nakajima Y.

Pathol Int. 2014 Nov;64(11):581-4. doi: 10.1111/pin.12211. Epub 2014 Oct 27.

PMID:
25349101
48.

Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients.

Sho M, Murakami Y, Motoi F, Satoi S, Matsumoto I, Kawai M, Honda G, Uemura K, Yanagimoto H, Kurata M, Fukumoto T, Akahori T, Kinoshita S, Nagai M, Nishiwada S, Unno M, Yamaue H, Nakajima Y.

J Gastroenterol. 2015 Jun;50(6):694-702. doi: 10.1007/s00535-014-1005-4. Epub 2014 Oct 24.

PMID:
25341657
49.

Significant efficacy of new transcatheter arterial chemoembolization technique for hepatic metastases of pancreatic neuroendocrine tumors.

Akahori T, Sho M, Tanaka T, Nishiofuku H, Kinoshita S, Nagai M, Kichikawa K, Nakajima Y.

Anticancer Res. 2013 Aug;33(8):3355-8.

PMID:
23898103
50.

Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Nagai M, Sho M, Satoi S, Toyokawa H, Akahori T, Yanagimoto H, Yamamoto T, Hirooka S, Yamaki S, Kinoshita S, Nishiwada S, Ikeda N, Kwon AH, Nakajima Y.

J Hepatobiliary Pancreat Sci. 2014 Mar;21(3):186-92. doi: 10.1002/jhbp.14. Epub 2013 Jun 20.

PMID:
23798362

Supplemental Content

Loading ...
Support Center